Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Cote

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Plos One|July 2, 2014
Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1Edwin Choy, Laura E MacConaill, Gregory M Cote, et al.
British Journal of Cancer|January 29, 2024
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumoursHoward A Burris, Jordan Berlin, Tobias Arkenau, et al.
The Oncologist|May 7, 2022
Phase II Study of Cabozantinib in Patients With Bone MetastasisEdwin Choy, Gregory M Cote, M Dror Michaelson, et al.
Sarcoma|January 10, 2020
Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single InstitutionRuoyu Miao, Edwin Choy, Kevin A Raskin, et al.
Cancer Immunology Research|May 29, 2014
Programmed cell death ligand 1 expression in osteosarcomaJacson K Shen, Gregory M Cote, Edwin Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2018
A Phase 1 Study of Nilotinib Plus Radiation in High-Risk ChordomaGregory M Cote, Constance M Barysauskas, Thomas F DeLaney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 14, 2011
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphomaGregory M Cote, Ephraim P Hochberg, Alona Muzikansky, et al.
The American Journal of Surgical Pathology|May 20, 2020
Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative AnalysisYin P Hung, Julio A Diaz-Perez, Gregory M Cote, et al.
Investigational New Drugs|September 17, 2025
Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumorsAlejandro Falcón, Santiago Ponce, Gregory M Cote, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNSTRuoyu Miao, Haotong Wang, Alex Jacobson, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Plos One|July 2, 2014
Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1Edwin Choy, Laura E MacConaill, Gregory M Cote, et al.
British Journal of Cancer|January 29, 2024
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumoursHoward A Burris, Jordan Berlin, Tobias Arkenau, et al.
The Oncologist|May 7, 2022
Phase II Study of Cabozantinib in Patients With Bone MetastasisEdwin Choy, Gregory M Cote, M Dror Michaelson, et al.
Sarcoma|January 10, 2020
Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single InstitutionRuoyu Miao, Edwin Choy, Kevin A Raskin, et al.
Cancer Immunology Research|May 29, 2014
Programmed cell death ligand 1 expression in osteosarcomaJacson K Shen, Gregory M Cote, Edwin Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2018
A Phase 1 Study of Nilotinib Plus Radiation in High-Risk ChordomaGregory M Cote, Constance M Barysauskas, Thomas F DeLaney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 14, 2011
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphomaGregory M Cote, Ephraim P Hochberg, Alona Muzikansky, et al.
The American Journal of Surgical Pathology|May 20, 2020
Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative AnalysisYin P Hung, Julio A Diaz-Perez, Gregory M Cote, et al.
Investigational New Drugs|September 17, 2025
Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumorsAlejandro Falcón, Santiago Ponce, Gregory M Cote, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNSTRuoyu Miao, Haotong Wang, Alex Jacobson, et al.
Pageof 10